Short-term notes receivable, net of allowance for credit losses of 261,000 at september 30, 2025 and 360,000 at december 31, 2024
4,348,107
3,312,496
2,229,563
Total current assets
43,468,364
3,960,673
2,845,538
Other assets
2,000
2,000
2,000
Total assets
43,470,364
3,962,673
2,847,538
Accounts payable
1,282,224
1,404,611
1,530,735
Accrued expenses and other current liabilities
41,896
379,633
210,104
Warrant liabilities
362,323
213,976
229,950
Convertible debt
339,736
142,069
-
Promissory notes
2,897,107
3,474,667
843,615
Total current liabilities
4,923,286
5,614,956
2,814,404
Preferred stock, 0.001 par value 15,000,000 shares authorized 45,044 and 6,256 shares issued and outstanding as of september 30, 2025 and december 31, 2024, respectively
36,100,334
2,790,007
2,823,094
Common stock, 0.001 par value 225,000,000 shares authorized 3,056,822 and 736,431 shares issued and outstanding as of september 30, 2025 and december 31, 2024, respectively
67,734
66,213
66,203
Additional paid-in capital
131,809,991
122,884,659
122,851,582
Accumulated deficit
-129,430,981
-127,393,162
-125,707,745
Total stockholders equity
-
-
33,134
Total stockholders equity (deficit)
38,547,078
-1,652,283
-
Total liabilities & stockholders equity (deficit)
43,470,364
3,962,673
2,847,538
Unit: Dollar. Numbers labeled with * are estimated quarterly values.
Time Plot
Show the time plot by selecting a row from the table.